BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17284253)

  • 1. Translocation of heparanase into nucleus results in cell differentiation.
    Nobuhisa T; Naomoto Y; Okawa T; Takaoka M; Gunduz M; Motoki T; Nagatsuka H; Tsujigiwa H; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Kurebayashi J; Nakajima M; Taniguchi S; Sagara J; Dong J; Tanaka N
    Cancer Sci; 2007 Apr; 98(4):535-40. PubMed ID: 17284253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase regulates esophageal keratinocyte differentiation through nuclear translocation and heparan sulfate cleavage.
    Kobayashi M; Naomoto Y; Nobuhisa T; Okawa T; Takaoka M; Shirakawa Y; Yamatsuji T; Matsuoka J; Mizushima T; Matsuura H; Nakajima M; Nakagawa H; Rustgi A; Tanaka N
    Differentiation; 2006 Jun; 74(5):235-43. PubMed ID: 16759289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton.
    Galigniana MD; Scruggs JL; Herrington J; Welsh MJ; Carter-Su C; Housley PR; Pratt WB
    Mol Endocrinol; 1998 Dec; 12(12):1903-13. PubMed ID: 9849964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells.
    Benhamron S; Nechushtan H; Verbovetski I; Krispin A; Abboud-Jarrous G; Zcharia E; Edovitsky E; Nahari E; Peretz T; Vlodavsky I; Mevorach D
    J Immunol; 2006 Jun; 176(11):6417-24. PubMed ID: 16709798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein 90 interacts with vitamin D receptor in human leukemia cells.
    Marcinkowska E; Gocek E
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):114-6. PubMed ID: 20138989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDN-1 induces cell differentiation toward apoptosis in promyelocytic leukemia cells depending on its selective effect on client proteins of Hsp90.
    Qi X; Zhang X; Liu X; Tang W; Dai J; Chen A; Lin Q; Zhu T; Li J
    Toxicol Appl Pharmacol; 2021 Apr; 417():115459. PubMed ID: 33609515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid-induced nuclear translocation of heparanase uncouples glucose metabolism in endothelial cells.
    Wang F; Wang Y; Zhang D; Puthanveetil P; Johnson JD; Rodrigues B
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):406-14. PubMed ID: 22116097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting GRP75 improves HSP90 inhibitor efficacy by enhancing p53-mediated apoptosis in hepatocellular carcinoma.
    Guo W; Yan L; Yang L; Liu X; E Q; Gao P; Ye X; Liu W; Zuo J
    PLoS One; 2014; 9(1):e85766. PubMed ID: 24465691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of nuclear heparanase induces differentiation of human mammary cancer cells.
    Nobuhisa T; Naomoto Y; Takaoka M; Tabuchi Y; Ookawa K; Kitamoto D; Gunduz E; Gunduz M; Nagatsuka H; Haisa M; Matsuoka J; Nakajima M; Tanaka N
    Biochem Biophys Res Commun; 2005 May; 331(1):175-80. PubMed ID: 15845375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human heparanase nuclear localization and enzymatic activity.
    Schubert SY; Ilan N; Shushy M; Ben-Izhak O; Vlodavsky I; Goldshmidt O
    Lab Invest; 2004 May; 84(5):535-44. PubMed ID: 15034597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsp90 inhibitor AT-533 blocks HSV-1 nuclear egress and assembly.
    Li F; Jin F; Wang Y; Zheng D; Liu J; Zhang Z; Wang R; Dong D; Zheng K; Wang Y
    J Biochem; 2018 Dec; 164(6):397-406. PubMed ID: 30107464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells.
    Fiskus W; Rao R; Fernandez P; Herger B; Yang Y; Chen J; Kolhe R; Mandawat A; Wang Y; Joshi R; Eaton K; Lee P; Atadja P; Peiper S; Bhalla K
    Blood; 2008 Oct; 112(7):2896-905. PubMed ID: 18660379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus.
    Czar MJ; Galigniana MD; Silverstein AM; Pratt WB
    Biochemistry; 1997 Jun; 36(25):7776-85. PubMed ID: 9201920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of N-terminal ATPase on HSP90 attenuates colitis through enhanced Treg function.
    Collins CB; Aherne CM; Yeckes A; Pound K; Eltzschig HK; Jedlicka P; de Zoeten EF
    Mucosal Immunol; 2013 Sep; 6(5):960-71. PubMed ID: 23321985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brassinosteroid nuclear signaling recruits HSP90 activity.
    Samakovli D; Margaritopoulou T; Prassinos C; Milioni D; Hatzopoulos P
    New Phytol; 2014 Aug; 203(3):743-57. PubMed ID: 24807419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating human leukemia cells express heparanase that degrades heparan sulfate in subendothelial extracellular matrix.
    Yahalom J; Fibach E; Bar-Tana R; Fuks Z; Vlodavsky I
    Leuk Res; 1988; 12(9):711-7. PubMed ID: 2973542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular stress-inducing compounds increase osteoclast formation in a heat shock factor 1 protein-dependent manner.
    Chai RC; Kouspou MM; Lang BJ; Nguyen CH; van der Kraan AG; Vieusseux JL; Lim RC; Gillespie MT; Benjamin IJ; Quinn JM; Price JT
    J Biol Chem; 2014 May; 289(19):13602-14. PubMed ID: 24692538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of chemotherapeutics by the Hsp90 antagonist geldanamycin requires a steady serum condition.
    Burkitt M; Magee C; O'Connor D; Campbell F; Cornford P; Greenhalf W
    Mol Carcinog; 2007 Jun; 46(6):466-75. PubMed ID: 17219417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of nuclear retention of glucocorticoid receptor by nuclear Hsp90.
    Tago K; Tsukahara F; Naruse M; Yoshioka T; Takano K
    Mol Cell Endocrinol; 2004 Jan; 213(2):131-8. PubMed ID: 15062560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of HSP90 activity negatively modulates myogenic differentiation and cell survival in C2C12 cells.
    Wagatsuma A; Shiozuka M; Kotake N; Takayuki K; Yusuke H; Mabuchi K; Matsuda R; Yamada S
    Mol Cell Biochem; 2011 Dec; 358(1-2):265-80. PubMed ID: 21739150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.